A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
Public ClinicalTrials.gov record NCT00737529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Single-Arm, Open-Label Study To Determine The Efficacy And Safety Of Single-Agent Lenalidomide (Revlimid®) In Patients With Mantel Cell NHL Who Have Relapsed Or Progressed After Treatment With Bortezomib Or Are Refractory To Bortezomib
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and efficacy of Lenalidomide (Revlimid (R)) in subjects with mantle cell lymphoma who have relapsed, progressed or are refractory to bortezomib.
Study identification
- NCT ID
- NCT00737529
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 21, 2008
- Primary completion
- Apr 5, 2016
- Completion
- Nov 7, 2017
- Last update posted
- Dec 12, 2018
2008 – 2017
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| UCSD Moores Cancer Center | La Jolla | California | 92093 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| Tower Cancer Research Foundation | Los Angeles | California | 90211 | — |
| Boca Raton Community Hospital, Inc., Research Dept. | Boca Raton | Florida | 33486 | — |
| Pasco Hernando Oncology Associates, PA | Brooksville | Florida | 34613 | — |
| Broward General Medical Center | Fort Lauderdale | Florida | 33316 | — |
| MD Anderson Cancer Center, Orlando Regional Healthcare | Orlando | Florida | 32806 | — |
| Lake County Oncology and Hematology | The Villages | Florida | 32159 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Loyola University Medical Center - Smith | Maywood | Illinois | 60153 | — |
| Indiana University Cancer Center | Indianapolis | Indiana | 46202 | — |
| Alvin and Lois Lapidus Cancer Institute Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| University of Massachusetts Medical Center | Worcester | Massachusetts | 01655 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201-2014 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University Siteman Cancer Center | St Louis | Missouri | 63110 | — |
| University of Nebraska | Omaha | Nebraska | 68198-7680 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| NYU School of Medicine | New York | New York | 10016 | — |
| University of Rochester Cancer Center, James P. Wilmot Cancer Center | Rochester | New York | 14642 | — |
| Presbyterian Hospital | Charlotte | North Carolina | 28204 | — |
| Temple University School of Medicine | Philadelphia | Pennsylvania | 19140 | — |
| Hillman Cancer Institute at UPMC | Pittsburgh | Pennsylvania | 15232 | — |
| South Carolina Cancer Specialists | Hilton Head Island | South Carolina | 29926 | — |
| Avera Cancer Institute | Sioux Falls | South Dakota | 57105 | — |
| University of Tennessee Cancer Institute | Memphis | Tennessee | 38104 | — |
| University of Virginia Cancer Center Clinical Trials Office | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00737529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2018 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00737529 live on ClinicalTrials.gov.